Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 4, 1997, Pages 469-473

  Lazzarotto, Tiziana ^a   Spezzacatena, Patrizia ^a   Pradelli, Paola ^a   Abate, Davide A ^a   Varani, Stefania ^a   Landini, Maria Paola ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ANTIBODY SPECIFICITY; ARTICLE; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE DEFICIENCY; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS DETECTION;

EID: 0030860631     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.4.469-473.1997     Document Type: Article

References (28)

1. Basson, J., J. C. Tardy, and M. Aymard. 1989. Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection. Arch. Virol. 108:259-270.
2. Blackburn, N. K., T. G. Besselaar, B. D. Schoub, and K. F. O'Connell. 1991. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. J. Med. Virol. 33:6-9.
3. Boppana, S. B., and W. J. Britt. 1995. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J. Infect. Dis. 171:1115-1121.
4. Britt, W. J., and C. A. Alford. 1996. Cytomegalovirus, p. 2493-2523. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
5. Dal Monte, P., T. Lazzarotto, A. Ripalti, and M. P. Landini. 1996. Human cytomegalovirus infection: a complex diagnostic problem in which molecular biology has induced a rapid evolution. Intervirology 39:193-203.
6. Genevieve, R. E., P. Barjot, M. Campet, A. Vabret, M. Herlicoviez, G. Muller, G. Levy, B. Guillois, and F. Freymuth. 1996. Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum. J. Med. Virol. 50:9-15.
7. Gleaves, C. A., T. F. Smith, E. A. Shuster, and G. R. Pearson. 1984. Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by use of low-speed centrifugation and monoclonal antibody to an early antigen. J. Clin. Microbiol. 19:917-919.
8. Gleaves, C. A., S. F. Wendt, D. R. Dobbs, and J. D. Meyers. 1990. Evaluation of the CMV-CUBE assay for detection of cytomegalovirus serological status in marrow transplant patients and marrow donors. J. Clin. Microbiol. 28: 841-842.
9. Hedman, K., and S. A. Rousseau. 1989. Measurement of avidity of specific IgG for verification of recent primary rubella. J. Med. Virol. 27:288-292.
10. Ho, M. 1991. Cytomegalovirus. Biology and infection, 2nd ed. Plenum Medical Press, New York, N.Y.
11. Kangro, H. O., S. Manzoor, and D. R. Harper. 1991. Antibody avidity following varicella-zoster virus infections. J. Med. Virol. 33:100-105.
12. Landini, M. P. 1993. New approaches and perspectives in cytomegalovirus diagnosis. Prog. Med. Virol. 4:157-177.
13. Landini, M. P., T. Lazzarotto, G. T. Maine, A. Ripalti, and R. Flanders. 1995. Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay. J. Clin. Microbiol. 33:2535-2542.
14. Lazzarotto, T., B. Dalla Casa, B. Campisi, and M. P. Landini. 1992. Enzymelinked immunoadsorbent assay for the detection of cytomegalovirus-IgM: comparison between eight commercial kits, immunofluorescence and immunoblotling. J. Clin. Lab. Anal. 6:216-218.
15. Lazzarotto, T., G. Furlini, M. C. Re, E. Ramazzotti, B. Campisi, and M. P. Landini. 1994. Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV. Arch. Virol. 135:13-28.
16. Lazzarotto, T., G. T. Maine, P. Dal Monte, A. Ripalti, and M. P. Landini. 1996. A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection. J. Clin. Microbiol. 35:393-397.
17. Lazzarotto, T. Unpublished data.
18. Lutz, E., K. N. Ward, and J. J. Gray. 1994. Maturation of antibody avidity after primary human cytomegalovirus infection is delayed in immunosuppressed solid organ transplant patients. J. Med. Virol. 44:317-322.
19. Lutz, E., K. N. Ward, R. Szydlo, and J. M. Goldman. 1996. Cytomegalovirus antibody avidity in allogenic bone marrow recipients: evidence for primary or secondary humoral responses depending on donor immune status. J. Med. Virol. 49:61-65.
20. Nielsen, C. M., K. Hansen, H. M. K. Andersen, J. Gerstoff, and B. F. Verstergaard. 1987. An enzyme labelled nuclear antigen immunoassay for detection of cytomegalovirus IgM antibodies in human serum: specific and non-specific reactions. J. Med. Virol. 22:67-76.
21. Nielsen, S. L., I. Sørensen, and H. K. Andersen. 1988. Kinetics of specific immunoglobulins M, E, A, and G in congenital, primary, and secondary cytomegalovirus infection studied by antibody-capture enzyme-linked immunosorbcnt assay. J. Clin. Microbiol. 26:654-661.
22. Revello, M. G., M. Zavattoni, E. Percivalle, P. Grossi, and G. Gerna. 1989. Correlation between immunofluorescent detection of human cytomegalovirus immediate early antigens in polymorphonuclear leukocytes and viremia. J. Infect. Dis. 160:159-160.
23. Revello, M. G. Personal communication.
24. Tuokko, H. 1995. Detection of acute measles infections by indirect and μ-capture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulin G antibody avidity enzyme immunoassay. J. Med. Virol. 45:306-311.
25. van der Biji, W. J., R. Torensma, W. J. Son, J. Schirm, A. M. Tegzess, and T. H. The. 1988. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. J. Med. Virol. 25:179-188.
26. Ward, K. N., M. J. Sheldon, and J. J. Gray. 1991. Primary and recurrent cytomegalovirus infections have different effects on human herpesvirus-6 antibodies in immunosuppressed organ graft recipients: absence of virus cross-reactivity and evidence for virus interaction. J. Med. Virol. 34:258-267.
27. Ward, K. N., J. J. Gray, M. E. Joslin, and M. J. Sheldon. 1993. Avidity of IgG antibodies to human herpesvirus-6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross-reactivity with other herpesviruses. J. Med. Virol. 39:44-49.
28. Ward, K. N., W. Dhaliwal, K. L. Ashworth, E. J. Clutterbuck, and C. G. Teo. 1994. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. J. Med. Virol. 43:367-372.